✦ LIBER ✦

Consensus on future directions in Parkinson's disease research

✍ Scribed by Vicki Glaser

Book ID: 117756774
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 968 KB
Volume: 1
Category: Article
ISSN: 1357-4310
DOI: 10.1016/s1357-4310(95)93587-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future directions for research on Alzhei

Future directions for research on Alzheimer's disease

✍ Anne B. Young 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Future directions for research on Alzhei

Future directions for research on Alzheimer's disease

✍ Ivan Lieberburg 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Future directions in the treatment of Pa

Future directions in the treatment of Parkinson's disease

✍ Anthony H.V. Schapira 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The development of treatment for the symptoms of Parkinson's disease (PD) has been one of the most notable successes of neurology. Dopaminergic therapies in the form of levodopa, dopamine agonists, or monoamine oxidase B inhibitors significantly improve the characteristic motor symptoms of bradykine

Future directions for research in Alzhei

Future directions for research in Alzheimer's disease

✍ Leon J. Thal 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Levodopa/dopamine replacement strategies

Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions

✍ C. Warren Olanow 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Future directions for immune modulation

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease

✍ Kathleen A. Maguire-Zeiss; Howard J. Federoff 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB